% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Blum:305372,
      author       = {T. G. Blum and J. Vogel-Claussen and H. Hoffmann and M.
                      Reck and V. Harth and A. Faron and I. Dänschel and S.
                      Andreas and A. Rupp and R. Kaaks$^*$ and G. Schmid-Bindert},
      title        = {{W}hite paper on identification, information, and
                      eligibility assessment of potential participants in lung
                      cancer screening in {G}ermany. [{W}hitepaper zu
                      {I}dentifikation, {I}nformation und {E}ignungsprüfung von
                      potenziellen {T}eilnehmern an der
                      {L}ungenkrebsfrüherkennung in {D}eutschland.]},
      journal      = {Pneumologie},
      volume       = {nn},
      issn         = {0934-8387},
      address      = {Stuttgart},
      publisher    = {Thieme},
      reportid     = {DKFZ-2025-02113},
      pages        = {nn},
      year         = {2025},
      note         = {epub},
      abstract     = {The nationwide introduction of lung cancer screening using
                      low-dose computed tomography (LDCT) is imminent in Germany.
                      In contrast to other cancer screening programs, lung cancer
                      screening follows a risk-based approach and specifically
                      targets heavy current and former smokers aged 50 to 75
                      years. Following several years of pilot phases and
                      regulatory preparation, the Federal Joint Committee (G-BA)
                      decided in June 2025 to include this program as a regular
                      benefit covered by statutory health insurance starting in
                      2026.Evidence from large international studies demonstrates
                      a significant reduction in lung cancer mortality of
                      approximately $20\%.$ However, there are also risks such as
                      overdiagnosis, unnecessary invasive procedures in
                      false-positive findings, secondary cancers due to radiation
                      exposure, and psychological burden.Key factors for program
                      success include the structured involvement of qualified
                      physicians in the identification, information, and
                      assessment of eligibility of potential participants.
                      Physicians in the fields of general medicine, occupational
                      medicine, and internal medicine have been authorized after
                      specific qualification, the latter of which includes
                      pulmonologists - who, while not explicitly mentioned, will
                      certainly have the closest contact with the high-risk
                      population of smokers. This white paper provides practical
                      information and materials for participating in lung cancer
                      screening. It highlights the importance of dedicated
                      interdisciplinary collaboration to detect as many lung
                      cancer patients as possible at an early and therefore
                      potentially curable stage.},
      subtyp        = {Review Article},
      cin          = {C020},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:41086827},
      doi          = {10.1055/a-2697-6434},
      url          = {https://inrepo02.dkfz.de/record/305372},
}